학술논문

Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.
Document Type
Article
Source
NPJ Precision Oncology; 3/8/2022, Vol. 6 Issue 1, p1-9, 9p
Subject
IMMUNE checkpoint inhibitors
GERM cells
GENETIC variation
TRANSITIONAL cell carcinoma
TUMOR microenvironment
BLADDER cancer
HEREDITARY nonpolyposis colorectal cancer
Language
ISSN
2397768X
Abstract
Copyright of NPJ Precision Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)